Literature DB >> 10383603

Glucose metabolism and the postprandial state.

P J Lefèbvre1, A J Scheen.   

Abstract

Disturbances of postprandial glucose metabolism are now thought to contribute to cardiovascular disease. Postprandial glucose excursions can be affected by a number of factors, such as the types of carbohydrates ingested and the way they are metabolized. In Type 2 diabetes, factors that contribute to excessive postprandial glucose excursions include disruption of insulin secretion, insufficient inhibition of hepatic glucose production and defective glucose storage in muscle. A number of measures may attenuate excessive postprandial blood glucose excursions. These include a diet high in 'low glycaemic index' foods and treatment with drugs that improve or restore the hormonal response (e.g. the sulphonylureas and the newer beta-cell mediated insulinotropic drugs such as repaglinide), that improve insulin sensitivity or that delay gastric emptying.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383603     DOI: 10.1046/j.1365-2362.1999.00003.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

Review 1.  Modern pharmacotherapies for type 2 diabetes mellitus.

Authors:  S H Hsia
Journal:  J Natl Med Assoc       Date:  2001-09       Impact factor: 1.798

2.  Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study.

Authors:  Bente Bryhni; Egil Arnesen; Trond G Jenssen
Journal:  BMC Endocr Disord       Date:  2010-12-16       Impact factor: 2.763

3.  Objective Biomarkers for Total Added Sugar Intake - Are We on a Wild Goose Chase?

Authors:  Jimmy Chun Yu Louie
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

4.  Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective.

Authors:  Nicholaos Kakouros; Jeffrey J Rade; Antonios Kourliouros; Jon R Resar
Journal:  Int J Endocrinol       Date:  2011-08-21       Impact factor: 3.257

Review 5.  Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.

Authors:  Raminderjit Kaur; Manpreet Kaur; Jatinder Singh
Journal:  Cardiovasc Diabetol       Date:  2018-08-31       Impact factor: 9.951

Review 6.  Current State and Principles of Basal Insulin Therapy in Type 2 Diabetes.

Authors:  Hernando Vargas-Uricoechea
Journal:  J Clin Med Res       Date:  2022-01-29

Review 7.  The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation.

Authors:  Albino Carrizzo; Carmine Izzo; Marco Oliveti; Antonia Alfano; Nicola Virtuoso; Mario Capunzo; Paola Di Pietro; Mariaconsiglia Calabrese; Eros De Simone; Sebastiano Sciarretta; Giacomo Frati; Serena Migliarino; Antonio Damato; Mariateresa Ambrosio; Francesco De Caro; Carmine Vecchione
Journal:  Int J Mol Sci       Date:  2018-09-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.